Conclusion
In HFrEF patients with CS, RAVI/LAVI is an easily assessed novel
echocardiographic parameter. Increasing RAVI/LAVI is associated with
adverse clinical outcomes including death and need for durable
mechanical support. These findings suggest need for further
investigation into the use of RAVI/LAVI as a prognostic indicator in CS.